Adhera Therapeutics, Inc. (ATRX)
Develops experimental drugs to treat Parkinson's disease and Type 1 diabetes
$0.00+0.00%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+0.0%
The outlook
ATRX is trading at its 52-week low with minimal price movement today. The stock sits above both its 50- and 200-day moving averages, suggesting some near-term stability, though the neutral StockGlow score reflects mixed signals overall. At this price level, liquidity and fundamental data may be limited for typical investors.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$722
52-wk high
$0.01
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—